John Evans
2020
In 2020, John Evans earned a total compensation of $906.8K as CEO at Beam Therapeutics, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $367,813 |
|---|---|
| Salary | $529,271 |
| Other | $9,684 |
| Total | $906,768 |
Evans received $529.3K in salary, accounting for 58% of the total pay in 2020.
Evans also received $367.8K in non-equity incentive plan and $9.7K in other compensation.
Rankings
In 2020, John Evans' compensation ranked 9,028th out of 13,090 executives tracked by ExecPay. In other words, Evans earned more than 31.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,028 out of 13,090 | 31st |
Division Manufacturing | 3,856 out of 5,621 | 31st |
Major group Chemicals And Allied Products | 1,560 out of 2,254 | 31st |
Industry group Drugs | 1,363 out of 1,954 | 30th |
Industry Biological Products, Except Diagnostic Substances | 315 out of 411 | 23rd |
Source: SEC filing on April 23, 2021.
Evans' colleagues
We found two more compensation records of executives who worked with John Evans at Beam Therapeutics in 2020.